B Cell Modulation Strategies in Autoimmunity: The SLE Example

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|29|3155-3165

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.29, 2011-10, pp. : 3155-3165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An array of immunotherapeutic strategies for B-cell lymphomas

By Schultze J.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2059-2071

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxic T Cell Reponses Against Immunoglobulin in Malignant and Normal B Cells: Implications for Tumor Immunity and Autoimmunity

By  

Current Pharmaceutical Design, Vol. 9, Iss. 23, 2003-09 ,pp. : 1889-1903

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cell Endothelium Interaction in Autoimmunity

By  

Current Pharmaceutical Design, Vol. 10, Iss. 2, 2004-01 ,pp. : 171-181

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 345-350

Bentham Science Publishers

Access to resources Recommend Favorite

Natural and Adaptive Immune Cell-Based Therapies in Autoimmunity

By  

Current Medicinal Chemistry, Vol. 13, Iss. 13, 2006-06 ,pp. : 1557-1566

Bentham Science Publishers

Access to resources Recommend Favorite